G
Generate Biomedicines, Inc.
GENB · NASDAQ · Healthcare · 2.0B
Price · close
$16.12
+0.81% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-2.8×
Free cash flow yieldFCF yield
-32.2%
Return on equityROE
33.0%
Operating margin
-737.0%
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
-206.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.